Indication
Psoriasis
Psoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints. Read more about Psoriasis
375 drugs 194 manufacturers
Drugs that treat it
Common Psoriasis therapies.
DEXPAK (dexamethasone)
SOLU-MEDROL (methylprednisolone sodium succinate/PF)
DEXPAK (dexamethasone)
DERMAREST PSORIASIS (salicylic acid)
DERMAREST PSORIASIS (salicylic acid)
THERAPEUTIC DANDRUFF SHAMPOO (salicylic acid)
HIDEX (dexamethasone)
DXEVO (dexamethasone)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPsoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints.
Pathophysiologically driven by dysregulated innate and adaptive immune signaling—predominantly along the interleukin-23 and interleukin-17 pathways—it leads to marked keratinocyte hyperproliferation, abnormal epidermal differentiation, and local neoangiogenesis.
Clinically, it most frequently manifests as sharply demarcated, erythematous plaques covered by silvery-white scales that favor extensor surfaces, the scalp, and the lumbosacral region, although clinical variants include guttate, pustular, inverse, and erythrodermic presentations.
While it can present across any age group, it is frequently associated with systemic inflammatory comorbidities, including psoriatic arthritis, cardiometabolic disease, and psychological distress.
- medlineplus.gov
Psoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints While it can present across any age group, it is frequently associated with systemic inflammatory comorbidities, including psoriatic arthritis, cardiometabolic disease, and psychological distress
- nih.gov
Psoriasis is a chronic, immune-mediated inflammatory disorder primarily affecting the integumentary system, though it can involve extracutaneous tissues such as the joints
- nih.gov
Pathophysiologically driven by dysregulated innate and adaptive immune signaling—predominantly along the interleukin-23 and interleukin-17 pathways—it leads to marked keratinocyte hyperproliferation, abnormal epidermal differentiation, and local neoangiogenesis
- nih.gov
Pathophysiologically driven by dysregulated innate and adaptive immune signaling—predominantly along the interleukin-23 and interleukin-17 pathways—it leads to marked keratinocyte hyperproliferation, abnormal epidermal differentiation, and local neoangiogenesis While it can present across any age group, it is frequently associated with systemic inflammatory comorbidities, including psoriatic arthritis, cardiometabolic disease, and psychological distress
- nih.gov
Pathophysiologically driven by dysregulated innate and adaptive immune signaling—predominantly along the interleukin-23 and interleukin-17 pathways—it leads to marked keratinocyte hyperproliferation, abnormal epidermal differentiation, and local neoangiogenesis Clinically, it most frequently manifests as sharply demarcated, erythematous plaques covered by silvery-white scales that favor extensor surfaces, the scalp, and the lumbosacral region, although clinical variants include guttate, pustular...
- nih.gov
Clinically, it most frequently manifests as sharply demarcated, erythematous plaques covered by silvery-white scales that favor extensor surfaces, the scalp, and the lumbosacral region, although clinical variants include guttate, pustular, inverse, and erythrodermic presentations
- nih.gov
Clinically, it most frequently manifests as sharply demarcated, erythematous plaques covered by silvery-white scales that favor extensor surfaces, the scalp, and the lumbosacral region, although clinical variants include guttate, pustular, inverse, and erythrodermic presentations
- nih.gov
While it can present across any age group, it is frequently associated with systemic inflammatory comorbidities, including psoriatic arthritis, cardiometabolic disease, and psychological distress
Personalize your experience
Follow Psoriasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.